2012, Number 5
Next >>
Ann Hepatol 2012; 11 (5)
Hepatology Highlights
Pai R, Chen YY, Yoshida EM
Language: English
References: 10
Page: 615-617
PDF size: 77.02 Kb.
Text Extraction
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Ladero, et al. Progression of fibrosis is an mportant prognostic factor in chronic hepatitis C. Factors associated with accelerated fibrosis include age at infection, alcohol consumption and co-infection with either HIV or hepatitis B. To determine level of fibrosis, liver biopsy has been considered the gold standard for many years. It is not a perfect test, however, as sampling error and interobserver variation have been observed.
REFERENCES
Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol 1999; 31: 17–24.
Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-8.
Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol 1986; 2: 165-73.
Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy. Indications, adequacy, quality of specimens, and complications. A systematic review. J Hepatol 2007; 47: 284-94.
Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 686-93.
Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485-9.
Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
Foley DP, Fernandez LA, Leverson G, et al. Donation After Cardiac Death. Ann Surg 2005; 242: 724-31.
Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL. Donation After Cardiac Death as a Strategy to Increase Deceased Donor Liver Availability. Transactions of the Meeting of the American Surgical Association 2006; 124: 220-7.
Maheshwari A, Maley W, Li Z, Thuluvath PJ. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007; 13: 1645–53.
Full text